A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer

Author:                            

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.27, Iss.3, 2012-01, pp. : 657-663

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content